Phase II study of cediranib in patients with Malignant pleural mesothelioma: SWOG S0509

Linda L. Garland, Kari Chansky, Antoinette J. Wozniak, Anne S. Tsao, Shirish M. Gadgeel, Claire F. Verschraegen, Marco A. Dasilva, Mary Redman, David R Gandara

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of cediranib in patients with Malignant pleural mesothelioma: SWOG S0509'. Together they form a unique fingerprint.

Medicine & Life Sciences